LSH ROM's dag

Met veel genoegen nodig ik je namens LIOF uit voor de LSH ROM’s Dag. Deze dag is voor alle ROM-collega's die binnen de LSH-sector actief zijn op de taken innoveren, investeren en internationaliseren. Het doel is om kennis, expertise en meningen te delen over onderwerpen waar we allemaal mee te maken hebben. Tijdens de LSH ROM’s Dag 2025 wordt een (Engelstalige) workshop aangeboden die zich richt op onze rollen als ROM’s bij het ondersteunen van LSH-bedrijven bij de voorbereiding en lancering van hun product op de Amerikaanse markt.

Programma

• 12:15 – 13:00 Arrival and lunch
• 13:00 – 14:00 Theory & Strategic Framing
• “Why MedTech Startups Should Go U.S.-First — And How ROMs Can Help”
• 14:00 – 14:30 Break & Informal Peer Exchange
• 14:30 – 16:00 Breakout & Application Session
• “Start U.S. Smart: How ROMs Can Steer MedTech Startups Towards U.S. Market Success - Apply the U.S.-First Lens to Your Portfolio.
• 16:00 – 16:05 Closing
• 16:05 – 17:30 Networking

Graag wil ik jullie verzoeken om voor 6 november via het antwoordformulier aan te geven of je wel/niet komt en of je dan van de lunch en/of de borrel gebruik maakt.

Het volledige programma vind je hier.

Hopelijk tot in november!

Workshop

Develop Locally, Monetize Globally

Using USA Commercial Viability to Maximize Commercial Success

The United States is the largest healthcare market in the world. With only four percent of the world’s population, it represents roughly half of the $8 trillion worldwide health care economy. A successful USA-based commercial viability plan is essential for achieving the most successful acquisition for a medical-device company. But how does an international founder untap this market and its significant, worldwide product penetration and financial benefits, while preserving local operations and control over R&D, clinical trials, and other workstreams?

Using successful case studies from our decades of executive-level experience at multinational medical device companies and from advising start-up companies around the globe, the team of RQR Advisors, a global medical technology advisement firm, will explain how to develop a USA-based R&D, clinical, marketing regulatory, and reimbursement strategy, while still performing all of the critical components of these workstreams – up to the pivotal clinical trial – in the Netherlands. Developing such a strategy at the earliest stage in the development pipeline will decrease the risk of failure and increase the likelihood of success for founders and investors alike.

Objectives

By the end of the workshop, ROM professionals will:

• Understand why early U.S. market orientation is critical for MedTech startups,
• Be able to evaluate MedTech ventures for U.S. readiness,
• Gain tools and frameworks to coach and challenge startups to make the U.S. market a strategic focus early,
• Learn from case studies and practical investor tactics.